MBio Diagnostics is developing a portfolio of innovative tests for remote settings where lab-quality results are vital in making time-critical decisions. 

User-driven Design

The LightDeck® platform was designed to meet customer requirements:

  • Quality: Highly sensitive tests that deliver lab-quality results
  • Quick: Actionable data in 5-15 minutes with a simple procedure
  • Quantitative: More than yes/no to inform treatment decisions
  • Multiplex: Multiple tests per sample plus internal quality control to maximize confidence in results



The LightDeck COVID-19 Total Antibody Test is to determine past SARS-CoV-2 infection and potential immunity.


Host-response biomarkers in acute infection can help stage patients and inform treatment decisions.  

Cardiac Markers

We are developing a NextGen test for heart attack: a high-sensitivity troponin test and a 3-plex Cardiac Panel.

Veterinary Tests

MBio has an exclusive partnership with Heska Corporation in veterinary diagnostics. .

Water Tests

MBio offers tests for toxins associated with harmful algae bloom. 

MBio Diagnostics

5603 Arapahoe Avenue, Suite 1 | Boulder, CO | 80303 USA
Ph. (303) 952-2905 | |

Privacy Policy  |  Terms of UseLinkedIn